Galhaud Jean-Philippe, Scherrer Florian, Kemeny Stephan, Beauvieux Marie-Christine, Delevallee Céline
Groupe Labexa, Le Haillan, France.
Groupe Synlab, LBM Synlab Vallée du Rhône, Roussillon, France.
Ann Biol Clin (Paris). 2020 Dec 1;78(6):609-616. doi: 10.1684/abc.2020.1608.
Confronted with the COVID-19 crisis, healthcare professionals have had to tackle an epidemic crisis of a huge magnitude for which they were not prepared. Medical laboratories have been on the front line, from collecting samples to performing the analysis required to diagnose this new pathology. Responding to the needs and to the urgency of the situation, the authorities relied on the network of private laboratories. In France, private laboratory medicine represents 70% of overall activity, and with a network of more than 4,000 local laboratories, private laboratory medicine has been the cornerstone of the « screen-trace-isolate » strategy. This article gives feedback from private laboratory medicine professionals, directly involved in the reorganization carried out at the pre-analytical, analytical and post-analytical stages, during the crisis from March to October 2020.
面对新冠疫情危机,医护人员不得不应对一场规模巨大且毫无准备的流行病危机。医学实验室一直处于前线,从采集样本到进行诊断这种新病症所需的分析。为应对形势的需求和紧迫性,当局依靠私立实验室网络。在法国,私立检验医学占总体业务的70%,凭借4000多个地方实验室的网络,私立检验医学一直是“筛查-追踪-隔离”战略的基石。本文给出了直接参与2020年3月至10月危机期间在分析前、分析中和分析后阶段进行的重组工作的私立检验医学专业人员的反馈。